首页
订购/客服:400-666-5481

BMS-986020

    
10mM in DMSO

BMS-986020

源叶(MedMol)
S53587 一键复制产品信息
1257213-50-5
C29H26N2O5
482.53
AM152;AP-3152 free acidCyclopropanecarboxyl​ic acid,1-​[4'-​[3-​methyl-​4-​[[[(1R)​-​1-​phenylethoxy]​carbonyl]​amino]​-​5-​isoxazolyl]​[1,​1'-​biphenyl]​-​4-​yl]​-
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
S53587-1ml促销
10mM in DMSO

¥720.00 ¥648.00

9 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: LPA 受体拮抗剂;LPA Receptor Antagonists;;InformationBMS-986020 BMS-986020 (AM152, AP-3152 free acid) is a potent and selective antagonist of lysophosphatidic acid receptor 1 (LPA1) . BMS-986020 inhibits bile acid and phospholipid transporters with IC50 of 4.8 μM, 6.2 μM, and 7.5 μM for BSEP, MRP4, and MDR3, respectively. BMS-986020 has the potential for the treatment of idiopathic pulmonary fibrosis (IPF).TargetsLPA1 ; BSEP (Cell-free assay); MRP4 (Cell-free assay); MDR3 (Cell-free assay) ; 4.8 μM; 6.2 μM; 7.5 μM
靶点: IC50: 4.8 µM (BSEP); 6.2 µM (MRP4); 7.5 µM (MDR3)
参考文献: 1. Kihara Y, et al. Lysophospholipid receptors in drug discovery. Exp Cell Res. 2015 May 1;333(2):171-7.
2. Glenn Rosen, et al. LPA1 antagonists BMS-986020 and BMS-986234 for idiopathic pulmonary fibrosis: Preclinical evaluation of hepatobiliary homeostasis. European Respiratory Journal.3. Palmer SM, et al. Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis. Chest. 2018 Nov;154(5):1061-1069.
4. Adrienne Pena, et al. Autoradiographic evaluation of [18F]BMT-083133, a lysophosphatidic acid receptor 1 (LPA1) radioligand. The jornal of nuclear medicine.
保存条件: -80℃(运输条件:冰袋低温运输)
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 2.072 ml 10.362 ml 20.724 ml
5 mM 0.414 ml 2.072 ml 4.145 ml
10 mM 0.207 ml 1.036 ml 2.072 ml
50 mM 0.041 ml 0.207 ml 0.414 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×